Alan Shupe
Associate Director, Downstream Process Development Takeda Pharmaceutical
Seminars
Tuesday 13th October 2026
Breaking Down Case Study Learnings to Optimize Outsourced Bioconjugation & Minimize ADC Production Cost & Timelines
2:00 pm
- Understanding the financial and timeline risks associated with outsourced ADC manufacturing
- Contextualizing the significance of manufacturing partner selection with two early-stage conjugation program case studies
- Laying out adaptations to pivot and resolve conjugation issues to ultimately successfully deliver ADC clinical material
